Sona Nanotech Inc.
SNANF
Rank in Stocks
#25680
Based in Halifax, Canada, Sona Nanotech Inc. is a life sciences company focused... Based in Halifax, Canada, Sona Nanotech Inc. is a life sciences company focused on nanotechnology. It develops and commercializes gold nanorod solutions primarily for diagnostic applications. Their product portfolio includes the Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic test designed to detect the SARS-CoV-2 spike protein antigen in saliva from individuals suspected of having the virus. The company also offers Gemini and Omni gold nanorods, with the latter specifically engineered for medical uses, in addition to providing contract services. These versatile products are utilized in a wide array of applications, such as targeted drug delivery, environmental and food safety monitoring, cellular visualization, cancer therapy, liposuction treatments, and diagnostic tools for medical, consumer, military, and veterinary sectors.
Share Price
$0.196
Last synced: 2026-11-09
Market Cap
$24.35M
Change (1 day)
-2.00%
Change (1 year)
-51.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sona Nanotech Inc. (SNANF)
Category
Healthcare
EPS for Sona Nanotech Inc. (SNANF)
EPS as of July 2026 TTM: $-0.02
According to Sona Nanotech Inc.'s latest financial reports, its current EPS (TTM) is $-0.02. At the end of 2025 the company had an EPS of $-0.02, equal to its 2024 EPS of $-0.02.
EPS history for Sona Nanotech Inc. from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.02 | -23.50% |
| 2025 | $-0.02 | 6.74% |
| 2024 | $-0.02 | -8.10% |
| 2023 | $-0.02 | -17.00% |
| 2022 | $-0.03 | -80.42% |
| 2021 | $-0.13 | 72.27% |
| 2020 | $-0.08 | 114.90% |
| 2019 | $-0.03 | -75.83% |
| 2018 | $-0.14 | 625.63% |
| 2017 | $-0.02 | -33.22% |
| 2016 | $-0.03 | 277.22% |
| 2015 | $-0.01 | -64.57% |
| 2014 | $-0.02 | 209.72% |
| 2013 | $-0.01 | -89.96% |
| 2012 | $-0.07 | 464.57% |
| 2011 | $-0.01 | 2.42% |
| 2010 | $-0.01 | -93.31% |
| 2009 | $-0.19 | 475.78% |
| 2008 | $-0.03 | -12.50% |
| 2007 | $-0.04 | 85.86% |
| 2006 | $-0.02 | 500.00% |
| 2005 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $18.99 | -124,217.65% |
US
|
|
| $6.12 | -40,100.00% |
US
|
|
| $1.38 | -9,100.65% |
CN
|
|
| $14.83 | -97,028.10% |
US
|
|
| $5.09 | -33,367.97% |
US
|
Questions about Sona Nanotech Inc.'s earnings per share (EPS)
What is Sona Nanotech Inc.'s earnings per share (EPS)?
Sona Nanotech Inc.'s earnings per share (EPS) over the last twelve months is $-0.02, as of Jul 2026.
What was Sona Nanotech Inc.'s earnings per share (EPS) in 2025?
In 2025, Sona Nanotech Inc.'s earnings per share (EPS) was $-0.02, compared with $-0.02 in 2024.
How has Sona Nanotech Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Sona Nanotech Inc.'s earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2021 ($-0.13).
How does Sona Nanotech Inc.'s earnings per share (EPS) compare with similar companies?
Sona Nanotech Inc.'s earnings per share (EPS) ($-0.02) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.